Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Using human fat tissue derived stem cells in micrografts can safely and effectively increase hair density in people with hair loss.

PRP injections are not proven effective for treating erectile dysfunction.

Minoxidil helps restore thymus size in 22q11.2 deletion syndrome.

The laser system can safely improve recovery and quality of life for cervical cancer patients after surgery.

Polarized microscopy helps identify hair irregularities in genetic disorders.

A treatment called Cellcurin, combined with microneedling, significantly increased hair density and diameter in patients with hair loss.

An imbalanced scalp microbiome may worsen alopecia areata severity and inflammation, but treatment can partially restore balance.

COPD flare-ups worsen life quality and increase hospital visits and costs.

The study suggests that analyzing DNA can help treat hair loss, but more research is needed.

The document summarizes medical findings on topics like heart rhythm treatment, sleep apnea therapy, and various health conditions and treatments.

Microbial imbalances in hair follicles may contribute to hair loss, especially in women.

The study found no significant difference in stress hormone levels between people with alopecia areata and healthy individuals, suggesting that the disease is not caused by an overactive stress response system.

Certain genes and high cholesterol levels increase heart disease risk in Ethiopian patients with high blood pressure.

Ritlecitinib effectively regrows hair in severe alopecia areata and is well tolerated.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.

People with vitiligo may have a higher rate of Helicobacter pylori infection, but the infection's severity doesn't affect how severe the vitiligo is.

Technology expands design thinking possibilities, requiring a hybrid, reflective approach.

Platelet-Rich Plasma (PRP) therapy can effectively treat various hair loss conditions, improve hair count, thickness, and density, and potentially speed up results when combined with surgical techniques.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Platelet-rich plasma (PRP) is a simple, cost-effective treatment that promotes hair growth and reduces hair loss, with high patient satisfaction.

New treatments for relapsing multiple sclerosis are more effective and convenient but have higher risks of serious side effects.

GLP-1 receptor analogs may help improve metabolism and reproductive health in people with PCOS and obesity.

Thyroid disorders can cause skin issues in children, so early detection and screening are important.

Autologous platelet concentrates can effectively treat oral lichen planus like topical steroids.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

New markers can detect tumors, aid drug delivery, and treat cancer effectively and safely.

Chronic critical illness often leads to long ICU stays and ongoing health issues after surviving the initial critical phase.

Derinat may improve hair growth and quality of life in hair loss patients by reducing oxidative stress.

Higher miR-34a levels and the A variant of the MIR-34A gene are linked to increased risk and severity of alopecia areata.